Corrigenda
- PMID: 33436165
- DOI: 10.1016/j.jaci.2020.11.003
Corrigenda
Erratum for
-
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.J Allergy Clin Immunol. 2020 Sep;146(3):595-605. doi: 10.1016/j.jaci.2020.05.032. Epub 2020 Jun 7. J Allergy Clin Immunol. 2020. PMID: 32524991 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources